Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 1 | 2024 | 83 | 0.870 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 47 | 0.820 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 342 | 0.660 |
Why?
|
| Neoplasms | 5 | 2023 | 3035 | 0.550 |
Why?
|
| Plant Leaves | 2 | 2015 | 77 | 0.530 |
Why?
|
| Brassica rapa | 1 | 2015 | 3 | 0.530 |
Why?
|
| Quantitative Trait Loci | 3 | 2016 | 607 | 0.510 |
Why?
|
| Gene Regulatory Networks | 2 | 2021 | 308 | 0.470 |
Why?
|
| Zebrafish | 3 | 2023 | 319 | 0.470 |
Why?
|
| Genome | 4 | 2023 | 386 | 0.460 |
Why?
|
| Adaptation, Physiological | 2 | 2015 | 314 | 0.460 |
Why?
|
| Phenotype | 6 | 2022 | 2439 | 0.440 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 1768 | 0.410 |
Why?
|
| Genotype | 2 | 2017 | 1848 | 0.390 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2019 | 131 | 0.390 |
Why?
|
| Databases, Genetic | 2 | 2021 | 263 | 0.340 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 2 | 2017 | 14 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1265 | 0.310 |
Why?
|
| Genomics | 5 | 2021 | 761 | 0.300 |
Why?
|
| Gene Expression Profiling | 4 | 2021 | 1429 | 0.290 |
Why?
|
| Mutation | 5 | 2024 | 4132 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2021 | 1371 | 0.260 |
Why?
|
| Receptors, Estrogen | 2 | 2019 | 393 | 0.260 |
Why?
|
| Software | 3 | 2022 | 665 | 0.260 |
Why?
|
| Neuroblastoma | 2 | 2021 | 394 | 0.250 |
Why?
|
| Genomic Instability | 2 | 2022 | 80 | 0.240 |
Why?
|
| Liquid Biopsy | 1 | 2023 | 33 | 0.220 |
Why?
|
| Thymocytes | 1 | 2022 | 31 | 0.210 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2022 | 80 | 0.210 |
Why?
|
| Cloud Computing | 1 | 2022 | 11 | 0.200 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2022 | 12 | 0.200 |
Why?
|
| Data Accuracy | 1 | 2022 | 32 | 0.200 |
Why?
|
| Antitubercular Agents | 1 | 2022 | 54 | 0.200 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 135 | 0.200 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2022 | 51 | 0.200 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 54 | 0.200 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 266 | 0.190 |
Why?
|
| Whole Genome Sequencing | 1 | 2022 | 87 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 2399 | 0.190 |
Why?
|
| Genome, Bacterial | 1 | 2022 | 148 | 0.190 |
Why?
|
| Genome, Viral | 1 | 2021 | 80 | 0.180 |
Why?
|
| DNA Methylation | 3 | 2021 | 657 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 31 | 0.180 |
Why?
|
| beta Catenin | 1 | 2022 | 266 | 0.180 |
Why?
|
| Humans | 24 | 2024 | 89063 | 0.180 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 459 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 282 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 447 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2024 | 382 | 0.170 |
Why?
|
| Serine Endopeptidases | 1 | 2020 | 146 | 0.170 |
Why?
|
| Nicotinamide N-Methyltransferase | 1 | 2019 | 6 | 0.170 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2022 | 195 | 0.170 |
Why?
|
| Retrospective Studies | 2 | 2024 | 9003 | 0.170 |
Why?
|
| Precision Medicine | 1 | 2024 | 410 | 0.170 |
Why?
|
| Haplotypes | 2 | 2023 | 637 | 0.160 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2019 | 36 | 0.160 |
Why?
|
| Vitiligo | 1 | 2017 | 17 | 0.150 |
Why?
|
| Endophenotypes | 1 | 2017 | 17 | 0.150 |
Why?
|
| MicroRNAs | 2 | 2021 | 551 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2022 | 398 | 0.150 |
Why?
|
| Proteomics | 1 | 2019 | 230 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.140 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2016 | 37 | 0.140 |
Why?
|
| Chromatin | 1 | 2019 | 397 | 0.140 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2016 | 49 | 0.140 |
Why?
|
| Brachypodium | 1 | 2016 | 7 | 0.140 |
Why?
|
| Cysteine Endopeptidases | 1 | 2016 | 88 | 0.140 |
Why?
|
| Personality | 1 | 2017 | 134 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 866 | 0.130 |
Why?
|
| Penile Implantation | 1 | 2016 | 14 | 0.130 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2016 | 75 | 0.130 |
Why?
|
| Penile Prosthesis | 1 | 2016 | 24 | 0.130 |
Why?
|
| Immunotherapy | 1 | 2021 | 669 | 0.130 |
Why?
|
| Penis | 1 | 2016 | 60 | 0.130 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 22 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 131 | 0.130 |
Why?
|
| Prognosis | 5 | 2022 | 3773 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 200 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.120 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 149 | 0.120 |
Why?
|
| Peritoneal Neoplasms | 1 | 2016 | 184 | 0.120 |
Why?
|
| Ecotype | 1 | 2014 | 7 | 0.120 |
Why?
|
| Panicum | 1 | 2014 | 5 | 0.120 |
Why?
|
| Exome | 1 | 2015 | 127 | 0.120 |
Why?
|
| Colonic Neoplasms | 1 | 2019 | 573 | 0.120 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2014 | 19 | 0.120 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 332 | 0.120 |
Why?
|
| Water | 1 | 2016 | 283 | 0.120 |
Why?
|
| Genetic Fitness | 1 | 2014 | 38 | 0.120 |
Why?
|
| Reproductive Isolation | 1 | 2014 | 30 | 0.120 |
Why?
|
| Impulsive Behavior | 1 | 2017 | 286 | 0.120 |
Why?
|
| Phylogeny | 4 | 2022 | 1182 | 0.110 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 3000 | 0.110 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 763 | 0.110 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 414 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 575 | 0.110 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 344 | 0.100 |
Why?
|
| Male | 8 | 2024 | 42251 | 0.100 |
Why?
|
| Melanoma | 1 | 2016 | 467 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 2552 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 2752 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 579 | 0.100 |
Why?
|
| Hypoxia | 1 | 2016 | 650 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1975 | 0.100 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2021 | 73 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1223 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 2 | 2021 | 69 | 0.090 |
Why?
|
| Datasets as Topic | 2 | 2020 | 75 | 0.090 |
Why?
|
| Inflammation | 1 | 2015 | 971 | 0.090 |
Why?
|
| Female | 11 | 2021 | 46011 | 0.080 |
Why?
|
| Quality of Life | 1 | 2017 | 1662 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2016 | 964 | 0.080 |
Why?
|
| Genome, Human | 2 | 2021 | 767 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2022 | 2863 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 771 | 0.060 |
Why?
|
| Animals | 5 | 2023 | 27317 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2019 | 481 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2016 | 478 | 0.060 |
Why?
|
| United States | 3 | 2021 | 6955 | 0.060 |
Why?
|
| Protein Binding | 2 | 2019 | 1487 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 1108 | 0.060 |
Why?
|
| Disease Progression | 2 | 2019 | 1488 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1157 | 0.050 |
Why?
|
| Chromosomes | 1 | 2023 | 97 | 0.050 |
Why?
|
| Computational Biology | 2 | 2016 | 542 | 0.050 |
Why?
|
| Chromosome Mapping | 2 | 2016 | 1076 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2880 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2022 | 66 | 0.050 |
Why?
|
| Immunoglobulins | 1 | 2022 | 144 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2022 | 126 | 0.050 |
Why?
|
| Transcriptome | 2 | 2016 | 628 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 149 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 451 | 0.050 |
Why?
|
| Chemokine CCL3 | 1 | 2021 | 12 | 0.050 |
Why?
|
| Adult | 5 | 2019 | 26507 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2022 | 117 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2021 | 112 | 0.050 |
Why?
|
| Viruses | 1 | 2021 | 78 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 235 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 114 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 177 | 0.040 |
Why?
|
| Controlled Before-After Studies | 1 | 2019 | 3 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2021 | 187 | 0.040 |
Why?
|
| Health Information Exchange | 1 | 2019 | 12 | 0.040 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2019 | 9 | 0.040 |
Why?
|
| S-Adenosylmethionine | 1 | 2019 | 15 | 0.040 |
Why?
|
| Risk Factors | 2 | 2021 | 5466 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 25863 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2020 | 227 | 0.040 |
Why?
|
| Niacinamide | 1 | 2019 | 116 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 236 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 582 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 2062 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 470 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 1533 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2019 | 509 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 280 | 0.040 |
Why?
|
| Base Sequence | 1 | 2021 | 2327 | 0.040 |
Why?
|
| Macrophages | 1 | 2020 | 571 | 0.040 |
Why?
|
| Histones | 1 | 2019 | 329 | 0.040 |
Why?
|
| HLA-A Antigens | 1 | 2016 | 40 | 0.040 |
Why?
|
| Mice | 2 | 2022 | 11737 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cloning, Organism | 1 | 2016 | 19 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 726 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 14 | 0.030 |
Why?
|
| Penile Induration | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mental Health | 1 | 2017 | 176 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 106 | 0.030 |
Why?
|
| Response Elements | 1 | 2016 | 65 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 294 | 0.030 |
Why?
|
| Cadaver | 1 | 2016 | 185 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 274 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 6288 | 0.030 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 134 | 0.030 |
Why?
|
| Health Status | 1 | 2017 | 370 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 136 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2016 | 215 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 3373 | 0.030 |
Why?
|
| Synteny | 1 | 2014 | 27 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 9237 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 1057 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2014 | 171 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 859 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 848 | 0.030 |
Why?
|
| Adipocytes | 1 | 2015 | 162 | 0.030 |
Why?
|
| Hybridization, Genetic | 1 | 2014 | 106 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2014 | 124 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2015 | 344 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2017 | 537 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 504 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 111 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2016 | 711 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1650 | 0.030 |
Why?
|
| Internet | 1 | 2015 | 318 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1855 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 19077 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 1310 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2362 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2014 | 405 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 2001 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1670 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1521 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2612 | 0.020 |
Why?
|
| Algorithms | 1 | 2015 | 1875 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6777 | 0.020 |
Why?
|